Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
This study has been completed.
Information provided by:
First received: September 12, 2005
Last updated: January 24, 2008
Last verified: January 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2005|
|Estimated Primary Completion Date:||No date given|